Evidence map›Paper›PMID 26694606›Full record

ArticleLipids2016

Novel Very Long-Chain α-Methoxylated Δ5,9 Fatty Acids from the Sponge Asteropus niger Are Effective Inhibitors of Topoisomerases IB.

Néstor M Carballeira, Nashbly Montano, Luis A Amador, Abimael D Rodríguez, Mikhail Y Golovko, Svetlana A Golovko, Rosa M Reguera, Raquel Álvarez-Velilla, Rafael Balaña-Fouce

Abstract read
In one paragraph

Article in Lipids, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB.International journal of molecular sciences · 2021
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Néstor M CarballeiraDepartment of Chemistry, University of Puerto Rico, Rio Piedras Campus, PO Box 23346, San Juan, PR, 00931-3346, USA. nestor.carballeira1@upr.edu.
Nashbly MontanoDepartment of Chemistry, University of Puerto Rico, Rio Piedras Campus, PO Box 23346, San Juan, PR, 00931-3346, USA.
Luis A AmadorDepartment of Chemistry, University of Puerto Rico, Rio Piedras Campus, PO Box 23346, San Juan, PR, 00931-3346, USA.
Abimael D RodríguezDepartment of Chemistry, University of Puerto Rico, Rio Piedras Campus, PO Box 23346, San Juan, PR, 00931-3346, USA.
Mikhail Y GolovkoDepartment of Basic Sciences, University of North Dakota, Grand Forks, ND, 58202-9037, USA.
Svetlana A GolovkoDepartment of Basic Sciences, University of North Dakota, Grand Forks, ND, 58202-9037, USA.
Rosa M RegueraDepartment of Biomedical Sciences, University of León, Campus de Vegazana s/n, 24071, León, Spain.
Raquel Álvarez-VelillaDepartment of Biomedical Sciences, University of León, Campus de Vegazana s/n, 24071, León, Spain.
Rafael Balaña-FouceDepartment of Biomedical Sciences, University of León, Campus de Vegazana s/n, 24071, León, Spain.
University of Puerto Rico at Río Piedras · PRUniversidad de León · ESUniversity of North Dakota · US

Funding

Upgrade Laboratories Facilities at UPR-Rio PiedrasR25GM061151 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI CARBALLEIRA, NESTOR MANUEL · 2001 to 2023
$32.5M
Pilot Projects CoreP30GM103329 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI GEIGER, JONATHAN DAVID · 2012 to 2016
$5.1M
Marine Fatty Acids as New Antifungal, Antimycobacterial, and Topo-l AgentsSC1GM084708 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI CARBALLEIRA, NESTOR MANUEL · 2008 to 2011
$986k
NIGMS NIH HHS 2R25GM061151-13NIGMS NIH HHS 5P30GM103329-02NIGMS NIH HHS P30 GM103329NIGMS NIH HHS R25 GM061151NIGMS NIH HHS SC1 GM084708NIGMS NIH HHS SC1GM084708
6 · The paper itself

Abstract

The novel fatty acids (2R,5Z,9Z)-2-methoxy-25-methyl-5,9-hexacosadienoic acid (1a) and (2R,5Z,9Z)-2-methoxy-24-methyl-5,9-hexacosadienoic acid (1b) were isolated in 80 % purity from the Caribbean sponge Asteropus niger by chloroform/methanol extraction followed by solvent partitioning and silica gel column chromatography. The compounds were characterized by utilizing a combination of gas chromatography-mass spectrometry, nuclear magnetic resonance, and circular dichroism. Acids 1a and 1b were not detected in the phospholipids (PtdCho and PtdIns) of the sponge, but rather as free FA and possibly in glycosylceramides. The mixtures of 1a and 1b displayed cytotoxicity towards THP-1 and HepG2 cells with EC50's between 41 and 35 μg/mL. Apoptosis was not the preferred mode of cell death induced by 1a-1b in the THP-1 cells. This implies other types of cytotoxicity mechanisms, such as membrane disruption and/or the inhibition (EC50 = 1.8 μg/mL) of the human topoisomerase IB enzyme (hTopIB), with a mechanism of inhibition different from the one displayed by camptothecin (CPT). In a separate experiment, the mixture of 1a and 1b also displayed cytotoxicity towards ex vivo mouse splenocytes infected with Leishmania infantum amastigotes (IC(50) = 0.17 mg/mL) and free living promastigotes (IC(50) = 0.34 mg/mL). It was also found that the FA were inhibitory of the Leishmania topoisomerase IB (LTopIB) with an EC(50) = 5.1 μg/mL. Taken together, 1a and 1b represent a new class of FA with potential as TopIB inhibitors that preferentially inhibit hTopIB over LTopIB.

Indexed as

AnimalsDNA TopoisomerasesFatty Acids, UnsaturatedGas Chromatography-Mass SpectrometryGlycosphingolipidsHep G2 CellsHumansLeishmania infantumLeishmaniasis, VisceralMagnetic Resonance SpectroscopyMicePoriferaTopoisomerase InhibitorsDNA TopoisomerasesFatty Acids, UnsaturatedGlycosphingolipidsTopoisomerase InhibitorsAsteropus nigerCancerLeishmania infantumLeishmaniasisMethoxylated fatty acidsSpongesTopoisomerase IB

Identifiers

PMID26694606
PMCPMC4809140
OpenAlexW2473784505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.